Probi AB

Activities: Ingredients Research & Development Active Nutrition

Within the Care and Wellness Division of Symrise, Probi is globally offering biotics solutions, focused on researching, manufacturing, and delivering biotics for supplements and functional food.

Visit website
Promoted Content Probi

Profile

Founded on science, and together with customers and research partners, Probi is striving towards a future in which as many people as possible can take control of their gut microbiome so that they can live better lives for longer. 

Probi

Born out of Lund University in Sweden in 1991, the Probi portfolio has grown to serve over 40 markets worldwide and holds multiple patents globally. 

Probi

As an integral part of Symrise AG and its Care & Wellness Division, Probi is further strengthening capabilities and global reach. As such, it leverages this combined strength to advance future-ready solutions in health and well-being.

Probi

Trending Articles

  1. Verb Biotics launches LX03 probiotic targeting gut-liver axis The self-affirmed GRAS strain — consistently found at higher abundance in lean, metabolically healthy adults — produces a novel bile salt hydrolase that modulates fat...
  2. Abbott to spin off nutrition business Abbott plans to separate its $8.5bn nutrition arm into an independent listed company by the end of 2027, as it trims its 2026 sales growth outlook
  3. NOW launches GLP-1 Metabolic Support supplement with Metabolaid and Reducose The firm has launched a metabolic health supplement combining Metabolaid, Reducose and berberine HCl to support post-meal glucose responses, appetite regulation and muscle...
  4. Rousselot launches NxCogni collgagen peptide ingredient for cognitive clarity The Nextida platform-derived ingredient concentrates neurosupportive peptides at 100x standard hydrolysed collagen levels — without adding in any stimulants
  5. True Protein unveils ‘world-first’ stable canned liquid creatine Australian brand’s 3 g creatine monohydrate canned drink promises label-accurate dosing without stabilisers, though independent testing on commercial batches is still to come

Upcoming event

Supply Side Global

26–30 October 2026 | Exhibition Conference | Las Vegas, US See all

Related Content

Research & Development
Probi review confirms LP299V boosts non-haeme iron absorption by up to 50% across dietary contexts

Probi review confirms LP299V boosts non-haeme iron absorption by up to 50% across dietary contexts

Published in Frontiers in Nutrition, the analysis positions LP299V as a strain-specific iron bioavailability enhancer — with particular relevance for women of reproductive age, pregnant women and female athletes with low iron stores
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development
Why oral probiotics need mouth-specific strains, not gut formulas

Why oral probiotics need mouth-specific strains, not gut formulas

As the oral microbiome market barrels towards a $3.6bn valuation, Probi's Dr Jessica Neilands explains how strain selection, delivery format and colonisation strategy are reshaping oral health formulation
Digestion
Probi celebrates 35 years of science and a new chapter with Symrise

Probi celebrates 35 years of science and a new chapter with Symrise

Together, the companies are creating new opportunities to accelerate research, expand innovation and bring new and exciting biotic solutions to customers and consumers around the world
Ingredients
Clinical study demonstrates Probi’s new dual-strain probiotic improves constipation in healthy adults

Clinical study demonstrates Probi’s new dual-strain probiotic improves constipation in healthy adults

Probi has announced new clinical evidence demonstrating that its new dual-strain probiotic formulation (comprising strains LP299V and LpGOS42) delivers statistically significant improvements in bowel regularity, stool consistency and digestive comfort
Research & Development
LP299V clinically validated in Japanese adults in probiotic-first for Asia

LP299V clinically validated in Japanese adults in probiotic-first for Asia

Probi and Nomura Dairy's landmark double-blind study confirms LP299V normalises bowel habits in Japanese adults — delivering population-specific evidence for formulators targeting Asia's functional food market
Research & Development
Study finds Probi's LP299V probiotic reduces gut inflammation in endurance runners

Study finds Probi's LP299V probiotic reduces gut inflammation in endurance runners

A new study of experienced runners has shown that four weeks of daily supplementation with LP299v significantly reduced exercise-induced gut inflammation and reduced kidney injury biomarkers following endurance races
Ingredients
Expanding microbiome innovation with postbiotics

Expanding microbiome innovation with postbiotics

During the past two decades, the human microbiome has evolved from an emerging research field into one of the most influential areas of innovation in health and nutrition, writes Fred Narbel, VP Sales and Marketing at Probi
Subscribe now